AKT1 and bladder transitional cell carcinoma: In our study, we found that targeting NOTCH3 effectively inhibited the growth and metastasis of BLCA by downregulating of the SPP1-PI3K/AKT axis, suggesting the potential value of targeting NOTCH3 as a promising therapeutic strategy for BLCA.